Nailesh Bhatt
Directeur/Membre du Conseil chez SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Fortune : 2 156 $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Pankaj Mohan | M | 60 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | 9 ans |
Donald Griffith | M | 75 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | 9 ans |
John Cini | M | 72 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | 13 ans |
Jay Cross | M | 53 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | 5 ans |
Albert Dyrness | M | 61 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | 5 ans |
Raghu Rao | M | 62 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | 5 ans |
Terence Anthony Rugg | M | 65 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | 6 ans |
Sheri Thomas | F | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | 15 ans |
Lori McNeill | F | 51 | 2 ans | |
Ajay Damani | M | - |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Bill Reid | M | - |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Cliff Montagnoli | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | 17 ans |
Nimisha Bhatt | F | - |
VGYAAN Pharmaceuticals LLC
VGYAAN Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology VGYAAN Pharmaceuticals LLC engages in developing and commercializing clinically critical therapies. It provides generics and 505(b)(2) drugs. The company was founded by Nailesh A. Bhatt and is headquartered in Skillman, NJ. | 6 ans |
Susan Dexter | F | 67 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | 4 ans |
Abraham Mathews | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
Brian K. Whisenant | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | 21 ans |
Richard Kenney | M | 66 | 3 ans | |
James Gale | M | 74 |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Eric Primelles-Perez | M | - |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Janice Cacace | F | - |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Simon Daw | M | - |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Ronald B. Watkins | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | 17 ans |
Manuel Dafonseca | M | - | 3 ans | |
Nikhil Puri | M | - |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Zack Scott | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
Frank Leo | M | 68 |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Jeffrey Edwards | M | - |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Vern Davenport | M | - |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
V. Kadhiresan | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
Roy Tanaka | M | 75 |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
Dan Cole | M | 77 |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
Lisa Jordan Dunlea | F | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
E. Ashton Poole | M | 58 |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
John Alexander Martin | M | 71 |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | 3 ans |
Clark C. Davis | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
Daryl R. Edmiston | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | 11 ans |
Phillip J. Carter | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
Randall K. Jones | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
David L. Stott | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
Rudy Davis | M | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 40 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Nailesh Bhatt
- Réseau Personnel